← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 10, 2015Last known activity
Nov 29, 2022
Timeline
2010s
- Dec 10, 2015
Oblato, Inc.— Founded
Drugs by trial phase (2 distinct, 5 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (6)
- NCT05518838Lead sponsorN/A—
- NCT05561374Lead sponsorPhase 1Nov 29, 2022
- NCT04388475Lead sponsorPhase 2May 25, 2020
- NCT04388475Study directorPhase 2May 25, 2020
- NCT03649464Lead sponsorPhase 1/Phase 2Apr 30, 2019
- NCT01672463Lead sponsorPhase 1Dec 1, 2012
Details
- Founded
- Princeton, NJ, US Dec 10, 2015
- Last known activity
- Nov 29, 2022